Although ADAM17′s protective role in the development of AD is mainly based on in vitro studies and in vivo studies are currently missing, in support of this evidence it has been recently reported that a rare variant leading to loss-of-function of ADAM17 is associated with the pathogenesis of AD in human [145]. The gene discussed is ADAM17; the disease is Alzheimer disease.